IPR Litigation Content No 4 by MR Deep Narayan

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

IPR LITIGATION 4

• The following defences are available :


• Challenges to the title of the claimant. Defendants can argue that the
claimant is not entitled to sue for infringement due to reasons such as
defective title.
• Grounds for revocation. All the grounds available to challenge the validity
of a patent are available as grounds for defending an infringement action
(see Question 9).
• "Gillette" defence. Indian courts recognise the Gillette defence as a valid
defence in an infringement action. The defendant can prove that the act
complained of was merely what was disclosed in a prior publication (which
can also be relied on against the validity of the patent), without any
substantial or patentable variation made (Hindusthan Lever Ltd v Godrej
Soaps Ltd [1996] AIR Cal 367; Raviraj Gupta v Acme Glass Mosaic
Industries (1994) 56 DLT 673). Therefore, either the defendant does not
infringe or the patent is invalid, if the patent covers prior art.
• Bolar exemption. India recognises the concept of Bolar exemption and borrows from Bolar
provisions under US law. Under section 107A (a) of the Patents Act 1970 the act of making,
constructing, using, selling, or importing a patented invention solely for uses related to the
development and submission of information required under any law in force in India will not
amount to infringement. In Bayer Corporation & Anr. v Union of India & Ors., 2010 (43) PTC 12
(Del), the Division Bench of the Delhi High Court held that a patent owner cannot seek to prevent
the Drug Controller General of India from processing applications for licences to manufacture
and/or market a generic version of a patented drug (generally referred to as "patent linkage").

• Parallel import. The import of a patented product by any person duly authorised under the law to
produce and sell or distribute this product is not considered to be an infringement.

• Patent applications made before 1 January 2005. Enterprises that have made significant
investments and were producing and marketing the product covered by a patent application under
the old Patent Act (before 1 January 2005) will continue to manufacture the product even after the
grant of a patent. No infringement proceeding can be instituted against these enterprises. A patent
holder can only be entitled to receive a reasonable royalty from the enterprises. This provision is
applicable until the patent applications that were made before 1 January 2005 are disposed of by
the Patent Office.
• .
• Innocent infringement. Although the fact that the
defendant was an innocent infringer is not a factor for
determining liability, it plays a role in determining whether
an account of profits and damages should be granted in
favour of the claimant. The Patents Act 1970 expressly
states that damages or accounts of profits will not be
granted against a defendant that proves that he/she was
not aware and did not have reasonable grounds to believe
that the patent existed at the date of the infringement.
• Experimental use. Any uses of a patented invention for the
sole purposes of experimentation or carrying on research,
including for educational purposes, are not considered as
acts of infringement.

You might also like